PFIZER INC Annual Amortization of Intangible Assets in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Pfizer Inc quarterly/annual Amortization of Intangible Assets history and growth rate from 2010 to 2023.
  • Pfizer Inc Amortization of Intangible Assets for the quarter ending March 31, 2024 was $1.3B.
  • Pfizer Inc annual Amortization of Intangible Assets for 2023 was $4.7B, a 30.6% increase from 2022.
  • Pfizer Inc annual Amortization of Intangible Assets for 2022 was $3.6B, a 2.7% decline from 2021.
  • Pfizer Inc annual Amortization of Intangible Assets for 2021 was $3.7B, a 8.82% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.7B +$1.1B +30.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $3.6B -$100M -2.7% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-23
2021 $3.7B +$300M +8.82% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-23
2020 $3.4B -$1.1B -24.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $4.5B Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2015 $3.8B -$300M -7.32% Jan 1, 2015 Dec 31, 2015 10-K 2016-02-29
2014 $4.1B -$700M -14.6% Jan 1, 2014 Dec 31, 2014 10-K 2016-02-29
2013 $4.8B -$500M -9.43% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $5.3B -$400M -7.02% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 $5.7B +$200M +3.64% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-28
2010 $5.5B Jan 1, 2010 Dec 31, 2010 10-K 2013-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.